Sun damage predisposes pediatric patients to melanoma
the ONA take:
According to new research published in the Journal of Investigational Dermatology, researchers from the St. Jude Children's Research Hospital-Washington University Pediatric Cancer Genome Project have found that melanoma in some adolescent and adult patients involve many of the same genetic mutations and would likely respond to the same treatment.
For the study, researchers included 23 patients ranging in age from 9 months of 19 years old with melanoma. Researchers sequenced each person's genome and found that among the 15 patients with conventional melanoma, their tumors included various genetic mutations that were mostly consistent with ultraviolet light damage.
"We were surprised to see that so many of the pediatric melanomas had genetic changes linked to UV damage," said Richard K. Wilson, Ph.D., director of The Genome Institute at Washington University School of Medicine in St. Louis.
"This in-depth look at the genomics of pediatric melanoma is extraordinarily important for diagnosis and for selecting treatments that give young patients the best chances of a cure."
Melanoma in some adolescent and adult patients involve many of the same genetic mutations and would likely respond to the same treatment.
- Health Care Expansion Tied to Increased Rates of Surgical Treatment of Thyroid Cancer
- Hormone Refractory Prostate Cancer Responds to Abiraterone Acetate in Some Cases
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Beans, Whole Grains in Diet Beneficial for Colorectal Cancer Survivors
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Rubraca Granted Accelerated FDA Approval for Advanced BRCA-positive Ovarian Cancer
- New Criteria for Appropriate Use of Bone Scintigraphy to Diagnose and Manage Prostate and Breast Cancer
- Primary Care Physicians Surveyed on Breast Cancer Screening Practices
- Low Acculturated Latina Women Reported Breast Cancer Treatment Experience Differently Than Other Groups
- Cost and Complication Rates Differ Among Early Breast Cancer Treatment Options
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|